When a clinic adopts a new piece of artificial intelligence software, the decision should be based on one thing: improving patient care. A recent move by one company in the health AI space is bringing this principle into sharp focus.
Commure, a company that develops and sells AI products to clinics, has officially terminated its program that paid for referrals to new customers. In simple terms, the financial incentive for one client to recommend Commure's products to another has been removed.
This decision, while specific to one company, touches on a vital issue for the entire digital health industry. As AI tools become more integrated into diagnostics, treatment planning, and clinic operations, patients and providers alike need to have complete confidence in the technology they use. The presence of referral fees can create the appearance—or the reality—of a conflict of interest, where recommendations might be influenced by financial gain rather than purely clinical merit.
At Medicup, we believe the foundation of digital healthcare is trust. Patients need to trust that the tools their providers use are the best available, and providers need to trust that the platforms they choose are secure, effective, and transparently priced. Commure's decision to end its referral payment program is a positive step toward building a more trustworthy ecosystem for health AI. It reinforces the idea that the value of a health technology product should speak for itself, driving adoption through proven results and patient benefits, not back-end deals.
Source: [STAT News](https://www.statnews.com/2026/08/13/commure-terminates-payments-under-customer-referral-programs/?utm_campaign=rss)